Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Flexion Therapeutics (FLXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 828,636
  • Shares Outstanding, K 37,820
  • Annual Sales, $ 360 K
  • Annual Income, $ -137,480 K
  • 36-Month Beta 0.76
  • Price/Sales 2,333.94
  • Price/Cash Flow N/A
  • Price/Book 4.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -1.24
  • Number of Estimates 4
  • High Estimate -1.14
  • Low Estimate -1.35
  • Prior Year -1.07
  • Growth Rate Est. (year over year) -15.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.82 +5.33%
on 08/16/18
27.84 -21.23%
on 07/18/18
-5.52 (-20.11%)
since 07/17/18
3-Month
20.82 +5.33%
on 08/16/18
29.10 -24.64%
on 06/20/18
-4.71 (-17.68%)
since 05/17/18
52-Week
19.06 +15.06%
on 10/26/17
32.25 -32.00%
on 10/06/17
-0.11 (-0.50%)
since 08/17/17

Most Recent Stories

More News
Shares of Flexion Therapeu Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (FLXN , SPPI , BLCM , IONS , IMGN )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

SPPI : 22.78 (-0.26%)
BLCM : 6.51 (+1.56%)
FLXN : 21.93 (+0.09%)
Flexion Therapeutics (FLXN) Reports Q2 Loss, Lags Revenue Estimates

Flexion Therapeutics (FLXN) delivered earnings and revenue surprises of 4.92% and -4.12%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

FLXN : 21.93 (+0.09%)
Flexion Therapeutics Reports Second-Quarter 2018 Financial Results and Recent Business Highlights

-- Company reported net ZILRETTA(triamcinolone acetonide extended-release injectable suspension) sales of $3.8 million in Q2 representing 73% growth over Q1

FLXN : 21.93 (+0.09%)
Flexion Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 7, 2018 / Flexion Therapeutics, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 4:30 PM Eastern Time....

FLXN : 21.93 (+0.09%)
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to nine new employees for an aggregate of 30,700 shares of common stock. The Compensation Committee of the Board...

FLXN : 21.93 (+0.09%)
Flexion Therapeutics Named one of Boston Business Journal's Best Places to Work for the Second Year in a Row

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has been named as one of the Boston Business Journal's "Best Places to Work" for the second year in a row. Flexion was ranked among the...

FLXN : 21.93 (+0.09%)
Free Stock Performance Review on Zoetis and Three Additional Generic Drugs Stocks

Stock Research Monitor: FLXN, MNTA, and PETQ

PETQ : 34.51 (-1.48%)
MNTA : 27.60 (+2.79%)
FLXN : 21.93 (+0.09%)
Anokion Elects Michael Clayman, M.D., as Chairman of its Board of Directors

Anokion ("Anokion" or the "Company"), a privately held biopharmaceutical company developing novel tolerance-inducing therapeutics for autoimmune diseases, today announced that Michael D....

FLXN : 21.93 (+0.09%)
Alcami's Extended Workbench Supports Commercial Supply of Flexion Therapeutics's ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)

Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announced the expanded deployment of its Extended Workbench...

FLXN : 21.93 (+0.09%)
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to eight new employees for an aggregate of 50,000 shares of common stock. The Compensation Committee of the...

FLXN : 21.93 (+0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade FLXN with:

Business Summary

Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United...

See More

Key Turning Points

2nd Resistance Point 22.64
1st Resistance Point 22.28
Last Price 21.93
1st Support Level 21.41
2nd Support Level 20.90

See More

52-Week High 32.25
Fibonacci 61.8% 27.21
Fibonacci 50% 25.65
Fibonacci 38.2% 24.10
Last Price 21.93
52-Week Low 19.06

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar